Barrier-penetrating liposome targeted delivery of basic fibroblast growth factor for spinal cord injury repair
Source abstract
Abstract
Nanoparticle technologies offer a non-invasive means to deliver basic fibroblast growth factor (bFGF) for the treatment of spinal cord injury (SCI). However, the inability of bFGF to accumulate at the injury site and inefficient penetration across the blood-spinal cord barrier (BSCB) remain challenges. The present study describes a dual-targeting liposome (bFGF@Lip-Cp&Rp) with injury lesion targeting and BSCB-penetrating capability to deliver bFGF for SCI treatment. The CAQK peptide (Cp) with injury lesion targeting ability and R2KC peptide (Rp) with BSCB-penetrating capability were grafted onto the liposomes for a flexible and non-invasive drug delivery systems preparation. Results exhibit that the dual-targeted liposomes could significantly cross the BSCB and accumulate at the injury site. During the early stage of SCI, bFGF@Lip-Cp&Rp promotes repair of BSCB and facilitates M2-polarization of macrophages. Regular delivery of bFGF@Lip-Cp&Rp increase HUVECs tube formation and angiogenesis, ameliorate the microenvironment of lesion site, suppress the neuronal apoptosis and axonal atrophy in SCI rats. Importantly, continuous treatment of bFGF@Lip-Cp&Rp supports the restoration of limb motor function in SCI rats. In summary, this research implies that the injury site-targeting and BSCB-penetrating liposomes could be a promising therapeutic approach for the treatment of SCI.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Spinal Cord Injury Research · Nerve injury and regeneration · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Patients with complete paralysis walk with spinal cord implant
2. Efficient delivery of nerve growth factors to the central nervous system for neural regeneration
3. Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials10.1016/S1474-4422(21)00464-6 ↗
4. Surgical decompression in acute spinal cord injury: earlier is better10.1016/S1474-4422(20)30478-6 ↗
5. The influence of timing of surgical decompression for acute spinal cord injury: a pooled analysis of individual patient data10.1016/S1474-4422(20)30406-3 ↗
6. Participation of people living with disabilities in physical activity: a global perspective10.1016/S0140-6736(21)01164-8 ↗
7. Required growth facilitators propel axon regeneration across complete spinal cord injury10.1038/s41586-018-0467-6 ↗
8. Effective modulation of CNS inhibitory microenvironment using bioinspired hybrid-nanoscaffold-based therapeutic interventions
9. Neural stem cell grafts form extensive synaptic networks that integrate with host circuits after spinal cord injury10.1016/j.stem.2020.07.007 ↗
10. Adhesive, stretchable, and spatiotemporal delivery fibrous hydrogels harness endogenous neural stem/progenitor cells for spinal cord injury repair10.1021/acsnano.1c06892 ↗
11. The roles and applications of neural stem cells in spinal cord injury repair10.3389/fbioe.2022.966866 ↗
12. Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury10.1126/science.abh3602 ↗
13. Highly permeable DNA supramolecular hydrogel promotes neurogenesis and functional recovery after completely transected spinal cord injury10.1002/adma.202102428 ↗
14. Microenvironment-responsive immunoregulatory electrospun fibers for promoting nerve function recovery10.1038/s41467-020-18265-3 ↗
15. Thermosensitive heparin-poloxamer hydrogel encapsulated bFGF and NGF to treat spinal cord injury10.1111/jcmm.15478 ↗
16. bFGF-sodium hyaluronate collagen scaffolds enable the formation of nascent neural networks after adult spinal cord injury10.1166/jbn.2019.2732 ↗
17. Nanostructured mineral coatings stabilize proteins for therapeutic delivery10.1002/adma.201701255 ↗
18. A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor10.1038/nchem.1573 ↗
19. EMSCs build an all-in-one niche via cell-cell lipid raft assembly for promoted neuronal but suppressed astroglial differentiation of neural stem cells
20. Multifunctional fibers as tools for neuroscience and neuroengineering10.1021/acs.accounts.7b00558 ↗
21. Liposomes with silk fibroin hydrogel core to stabilize bFGF and promote the wound healing of mice with deep second-degree scald10.1002/adhm.201700344 ↗
22. Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model10.1016/j.jconrel.2016.01.017 ↗
23. PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrier10.1016/j.biomaterials.2010.04.057 ↗
24. Nanomedicine for treating spinal cord injury10.1039/c3nr00957b ↗
25. BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS10.1016/j.biotechadv.2015.02.004 ↗
26. Nanoparticle-based delivery to treat spinal cord injury—a mini-review10.1208/s12249-021-01975-2 ↗
27. Multi-target approaches to CNS repair: olfactory mucosa-derived cells and heparan sulfates10.1038/s41582-020-0311-0 ↗
28. The biology of regeneration failure and success after spinal cord injury10.1152/physrev.00017.2017 ↗
29. Dual-functional hydrogel system for spinal cord regeneration with sustained release of arylsulfatase B alleviates fibrotic microenvironment and promotes axonal regeneration10.1016/j.biomaterials.2022.121526 ↗
30. Remodeling microenvironment for endogenous repair through precise modulation of chondroitin sulfate proteoglycans following spinal cord injury
31. Targeting chondroitin sulfate proteoglycans: an emerging therapeutic strategy to treat CNS injury10.1021/acschemneuro.0c00004 ↗
32. A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries10.1038/ncomms11980 ↗
33. Scar tissue-targeting polymer micelle for spinal cord injury treatment10.1002/smll.201906415 ↗
34. Novel multi-drug delivery hydrogel using scar-homing liposomes improves spinal cord injury repair10.7150/thno.26717 ↗
35. Recent advances in nanotherapeutic strategies for spinal cord injury repair10.1016/j.addr.2018.12.011 ↗
36. In situ-gelling starch nanoparticle (SNP)/O-carboxymethyl chitosan (CMCh) nanoparticle network hydrogels for the intranasal delivery of an antipsychotic peptide10.1016/j.jconrel.2020.12.050 ↗
37. Anti-inflammatory nanotherapeutics by targeting matrix metalloproteinases for immunotherapy of spinal cord injury
38. Integrin-targeted, short interfering RNA nanocomplexes for neuroblastoma tumor-specific delivery achieve MYCN silencing with improved survival10.1002/adfm.202104843 ↗
39. TAT-modified tetramethylpyrazine-loaded nanoparticles for targeted treatment of spinal cord injury10.1016/j.jconrel.2021.05.016 ↗
40. Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection10.1073/pnas.1816429115 ↗
41. Apamin-mediated actively targeted drug delivery for treatment of spinal cord injury: more than just a concept10.1021/mp500393m ↗
42. Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery10.1038/s41467-021-22594-2 ↗
43. TAT-modified tetramethylpyrazine-loaded nanoparticles for targeted treatment of spinal cord injury10.1016/j.jconrel.2021.05.016 ↗
44. Cell-surface interactions on arginine-rich cell-penetrating peptides allow for multiplex modes of internalization10.1021/acs.accounts.7b00221 ↗
45. Targeted miR-21 loaded liposomes for acute myocardial infarction10.1039/D0TB01821J ↗
46. Sphingosine 1-phosphate liposomes for targeted nitric oxide delivery to mediate anticancer effects against brain glioma tumors
47. TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury10.1186/s12951-020-00766-4 ↗
48. Multifunctional inverse opal film as a responsive drug carrier for spinal cord injury repair
49. Two sigma and two mu class genes of glutathione S-transferase in the waterflea Daphnia pulex: molecular characterization and transcriptional response to nanoplastic exposure10.1016/j.chemosphere.2020.126065 ↗
50. A macrophage-activating, injectable hydrogel to sequester endogenous growth factors for in situ angiogenesis10.1016/j.biomaterials.2017.04.042 ↗
51. Stimulation by exosomes from hypoxia preconditioned human umbilical vein endothelial cells facilitates mesenchymal stem cells angiogenic function for spinal cord repair
52. Macrophage phagocytosis after spinal cord injury: when friends become foes10.1093/brain/awab250 ↗
53. Cell-free extracts from human fat tissue with a hyaluronan-based hydrogel attenuate inflammation in a spinal cord injury model through M2 microglia/microphage polarization